Lars Ekman - May 15, 2024 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Role
Director
Signature
/s/ Michael J. Malecek, as Attorney-in-Fact for Lars G. Ekman
Stock symbol
PRTA
Transactions as of
May 15, 2024
Transactions value $
$0
Form type
4
Date filed
5/17/2024, 04:38 PM
Previous filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRTA Stock Option (Right to Buy) Award $0 +15K $0.00 15K May 15, 2024 Ordinary Shares 15K $22.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.